SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AlienTech who wrote (621)6/18/1998 6:48:00 PM
From: david  Read Replies (2) of 1016
 

AT:

Look at what you posted on VVUS long thread. You are close
to being kicked out of that thread. I don't understand why
you are aware of VVUS's problem so late but not a few months
ago. of course, you would be kicked out earlier if you had
been.

as I said before on that thread (that's reason i was kicked
out), VVUS is
exactly like some other ill-managed companies and there is
no way for it to go through this tough campaign with PFE
with the current management team. However, unlike others
who are negative on VVUS, i do think its product will have
some market share finally. Viagara is just too good to believe
and long term side effects may not be felt in short time.
but they do collect in human body and once one knows it will
be just too late. so I am neither long nor short on vvus now.
near term, it may go lower further unless something good
happen (e.g.,scripts up). I don't think the new plant approval
is that positive near term. Believe me, VVUS needs some MBA
to run it but not just a group of doctors. they are slow in
bussiness. i just wish VVUS could stand till the situation improved and that's why I am asking at what price VVUS will
be delisted from Nasdaq.

d.




Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext